Roche, Zealand Pharma in Pact of $ 5.3 billion for obesity medicines

Roche held the licensing of a new weight loss drug from Zealand Pharma, enhancing the efforts of medication manufacturers to enter the hot market dominated by Novo Nordisk and Eli Lilly & Co. Read more



Source link